Milestone(MIST)04-30 05:15
$Milestone(MIST)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001104659-24-054157 Act: 34 Size: 612 KB 网页链接查看全文
Milestone(MIST)05-13 19:35
$Milestone(MIST)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-060221 Act: 34 Size: 309 KB 网页链接查看全文
Milestone(MIST)05-29 19:35
$Milestone(MIST)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-065806 Act: 34 Size: 267 KB 网页链接查看全文
Milestone(MIST)07-16 04:05
$Milestone(MIST)$ 8-K Current report, items 1.01, 5.02, 5.08, 8.01, and 9.01 Accession Number: 0001104659-24-079854 Act: 34 Size: 374 KB 网页链接查看全文
Milestone(MIST)07-16 04:45
$Milestone(MIST)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-079882 Act: 34 Size: 5 MB 网页链接查看全文
Milestone(MIST)07-16 04:45
$Milestone(MIST)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-079881 Act: 34 Size: 1 MB 网页链接查看全文
Milestone(MIST)07-18 04:25
$Milestone(MIST)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-019662 Size: 9 KB 网页链接查看全文
Milestone(MIST)07-18 04:25
$Milestone(MIST)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-019666 Size: 9 KB 网页链接查看全文
Milestone(MIST)07-18 04:25
$Milestone(MIST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019668 Size: 5 KB 网页链接查看全文
用户48783635432019-05-10 13:02
【汇众医疗】$Milestone制药(MIST)$ Milestone Pharmaceuticals等五家生物技术公司本周登陆纳斯达克, $Axcella Health(AXLA)$ $NextCure(NXTC)$ Milestone的在研重磅药物心脏病鼻喷剂Etripamil已进入III期试验。Milestone提出在本次发行中出售500万股普通股,首次公开发行价格预计为每股14至16美...查看全文
用户48783635432019-05-10 12:56
【汇众医疗】$Cortexyme(CRTX)$ $Milestone制药(MIST)$ $Axcella Health(AXLA)$ 医疗IPO热度不减,4家生物技术公司登陆纳斯达克募资3.03亿美元,安永数据显示,尽管今年第一季度美国政府关闭时间最长, IPO 活动低迷,但医疗类 IPO 仍占主导地位,占北美地区20宗 IPO 的70%,该行业的热度远未降温...查看全文
美股指南2019-05-07 20:49
摘要: 医药股Milestone制药是一家三期临床阶段的生物制药公司, 于2019年5月9号美股上市, 股票代码: $Milestone制药(MIST)$, IPO 价格为: 14.00-16.00; $Bausch Health(BHC)$ $梯瓦制药(TEVA)$
公司简介
Milestone是一家三期临床阶段的生物制药公司,研发一种治疗心血管适应症的的药物, ...查看全文
美股大观2019-05-06 14:14
$Milestone制药(MIST)$
网页链接
这家生物制药公司应该是最近这几家里距离商业化最近的一家。招股书中预计2020年上半年能产生营收,也就是一年后。这次IPO募资公司能到六七千万美元,撑到那时候是没有一点问题。
近期这类生物制药临床阶段...查看全文
智通财经APP获悉,总部位于加拿大的Milestone Pharmaceuticals(MIST.US)当地时间周二宣布,美国食品和药物管理局(FDA)拒绝接受其主要候选药物etripamil的新药上市申请(NDA)。此负面消息一出,Milestone股价在美股盘前一度下跌约40%。 ... 网页链接
智通财经APP获悉,生物制药公司Milestone Pharmaceuticals(MIST.US)周一宣布,其主要药物etripamil在一项治疗阵发性室上性心动过速(PSVT)患者的3期临床试验中达到了主要终点。截至发稿,Milestone Pharmaceuticals盘前涨35.45%,报11.50... 网页链接
$Milestone(MIST)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-019662 Size: 9 KB 网页链接
$Milestone(MIST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019664 Size: 5 KB 网页链接
$Milestone(MIST)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-019666 Size: 9 KB 网页链接
$Milestone(MIST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019668 Size: 5 KB 网页链接
$Milestone(MIST)$ SC 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0000921895-24-001575 Act: 34 Size: 105 KB 网页链接
$Milestone(MIST)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-079880 Act: 34 Size: 155 KB 网页链接
$Milestone(MIST)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-079881 Act: 34 Size: 1 MB 网页链接
$Milestone(MIST)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-079882 Act: 34 Size: 5 MB 网页链接
$Milestone(MIST)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-079878 Act: 34 Size: 1 MB 网页链接
$Milestone(MIST)$ 8-K Current report, items 1.01, 5.02, 5.08, 8.01, and 9.01 Accession Number: 0001104659-24-079854 Act: 34 Size: 374 KB 网页链接